… for the patients treated with bortezomib [10–… systematic review and meta-analysis of clinical
trials to investigate the efficacy and safety of bortezomib for patients with previously untreated …

Full article: Bortezomib-based vs non-bortezomib-based post-transplantation treatment in
multiple myeloma patients: a systematic review and meta-analysis of Phase III randomized …

… systematic literature review and meta-analysis that assesses the efficacy and safety of
bortezomib-based retreatment in patients … /or refractory MM with previous exposure to bortezomib. …

… Unlike lenalidomide, the role of bortezomib in the consolidation or maintenance … meta-analysis
of randomized controlled trials (RCTs) to examine the efficacy and safety of bortezomib-…

… systematic review and meta-analysis examining the efficacy of bortezomib-based treatment
for MM patients … carry out randomized controlled trials on this special group of patients, which …

… systematic review of 4 randomized controlled trials and 8 retrospective trials comparing SC
to intravenous (IV) bortezomib … of this systematic review also suggested that SC bortezomib …

… induction therapy in patients with previously untreated myeloma. Overall, … patients, more
studies are still needed to assess clinical feasibility of such combinations. This systematic review …

… with meta-analyses of randomized controlled trials (RCT) was … : (1) be a systematic review
with meta-analysis of RCT; (2) be … Previously untreated patients with MM of any stage; Direct …

Full article: Bortezomib in combination with thalidomide or lenalidomide or doxorubicin
regimens for the treatment of multiple myeloma: a meta-analysis of 14 randomized controlled …

… III randomized controlled trials (RCTs) that compared the outcomes of bortezomib-based
and non-bortezomib-based maintenance therapies in newly diagnosed MM patients. Included …